Rotz L D, Dotson D A, Damon I K, Becher J A
Office of Bioterrorism Preparedness and Response Activity, USA.
MMWR Recomm Rep. 2001 Jun 22;50(RR-10):1-25; quiz CE1-7.
These revised recommendations regarding vaccinia (smallpox) vaccine update the previous Advisory Committee on Immunization Practices (ACIP) recommendations (MMWR 1991;40; No. RR-14:1-10) and include current information regarding the nonemergency use of vaccinia vaccine among laboratory and health-care workers occupationally exposed to vaccinia virus, recombinant vaccinia viruses, and other Orthopoxviruses that can infect humans. In addition, this report contains ACIP's recommendations for the use of vaccinia vaccine if smallpox (variola) virus were used as an agent of biological terrorism or if a smallpox outbreak were to occur for another unforeseen reason.
这些关于牛痘(天花)疫苗的修订建议更新了免疫实践咨询委员会(ACIP)先前的建议(《发病率与死亡率周报》1991年;40;第RR - 14号:1 - 10),并纳入了有关牛痘疫苗在职业上接触牛痘病毒、重组牛痘病毒以及其他可感染人类的正痘病毒的实验室和医护人员中的非紧急使用的最新信息。此外,本报告包含了ACIP关于在天花( Variola )病毒被用作生物恐怖主义制剂或因其他不可预见的原因发生天花疫情时使用牛痘疫苗的建议。